Meningeální forma Rosai-Dorfmanovy choroby

Stáhnout PDF English version

Autoři: O. Medek ¹; Petra Kašparová ² ; M. Bartoš ³; B. Klímová ¹; M. Vališ ¹; T. Kupsa ^4,5; J. M. Horáček ^4,5; H. Medková ⁶
Působiště autorů: Department of Neurology, Faculty of Medicine of Charles University and University Hospital in Hradec Králové, Czech Republic ¹; Department of Pathology, Faculty of Medicine of Charles University and University Hospital in Hradec Králové, Czech Republic ²; Department of Neurosurgery, Faculty of Medicine of Charles University and University Hospital in Hradec Králové, Czech Republic ³; Department of Military Internal Medicine and Military Hygiene, University of Defense, Faculty of Military Health Sciences, Hradec Králové, Czech Republic ⁴; Department of Internal Medicine IV – Hematology, University Hospital in Hradec Králové, Czech Republic ⁵; 2nd Department of Internal Medicine – Gastroenterology, Faculty of Medicine in Hradec Králové, Charles University and University Hospital Hradec Králové, Czech Republic ⁶
Vyšlo v časopise: Cesk Slov Neurol N 2021; 84(5): 493-495
Kategorie: Dopisy redakci
doi: https://doi.org/10.48095/cccsnn2021493

Zdroje

1. Destombes P. Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali (4 cases). Bull Soc Pathol Exot 1965; 58(6): 1169–1175.

2. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 1969; 87(1): 63–70.

3. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 1972; 30(5): 1174–1188. doi: 10.1002/1097-0142(197211)30:5<1174::aid-cncr2820300507>3.0.co;2-s.

4. Rosai-Dorfman Disease. National Organization for Rare Disorders. [online]. Available from URL: https://rarediseases.org/rare-diseases/rosai-dorfman-disease/.

5. Abla O, Jacobsen E, Picarsic J et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorman disease. Blood 2018; 131(26): 2877–2890. doi: 10.1182/blood-2018-03-839753.

6. Symss NP, Cugati G, Vasudevan MC et al. Intracranial Rosai Dorfman Disease: report of three cases and literature review. Asian J Neurosurg 2010; 5(2): 19–30.

7. Pulsoni A, Anghel G, Falcucci P et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai‐Dorfman disease): Report of a case and literature review. Am J Hematol 2002; 69: 67–71. doi: 10.1002/ajh.10008.

8. Dalia S, Sagatys E, Sokol L et al. Rosai-Dorfman disease: Tumor biology, clinical features, pathology, and treatment. Cancer Control 2014; 21(4): 322–327. doi: 10.1177/107327481402100408.

9. Grabczynska SA, Toh CT, Francis N et al. Rosai-Dorfman disease complicated by autoimmune haemolytic anemia: case report and review of multisystem disease with cutaneous infiltrates. Br J Dermatol 2001; 145(2): 323–326. doi:10.1046/j.1365-2133.2001.04325.x.

10. Shanmugam V, Margolskee E, Kluk M et al. Rosai-Dorfman disease harboring an activating KRAS K117N missense mutation. Head Neck Pathol 2016; 10(3): 394–399. doi:10.1007/s12105-016-0709-6.

11. Garces S, Medeiros LJ, Patel KP et al. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Wirchows Arch 2017; 471(4): 545–547.

12. Namoglu EC, Hughes ME, Plastaras JP et al. Management and outcomes of sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman Disease). Leuk Lymphoma. 2020; 61(4): 905–911. doi:10.1080/10428194.2019.1703971.

13. Maric I, Pittaluga S, Dale JK et al. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 2005; 29(7): 903–911. doi:10.1097/01.pas.0000157997.61177.08.

14. Xie Y, Pittaluga S, Price S et al. Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation. Haematologica 2017; 102(2): 364–372. doi:10.3324/haematol.2015.138081.

15. Amiji I, Mohammed U, Salum H et al. Rosai Dorfman Disease -A rare case of cervical lymphadenopathy. Clin Case Rep 2020; 8(12): 2712–2715. doi: 10.1002/ccr3.3255.

16. Petzold A, Thom M, Powell M et al. Relapsing intracranial Rosai-Dorfman disease. J Neurol Neurosurg Psychiatry 2001; 71: 538–541. doi: 10.1136/jnnp.71.4.538.

17. Mahzoni P, Zavareh MH, Bagheri M et al. Intracranial ROSAI-DORFMAN Disease. J Res Med Sci 2012;17(3): 304–307.

18. Forest F, N’Guyen AT, Fesselet J et al. Meningeal Rosai–Dorfman disease mimicking meningioma. Ann Hematol 2014; 93(6): 937–940. doi: 10.1007/s00277-013-1994-8.

19. Natarajan S, Post KD, Strauchen J et al. Primary intracerebral Rosai–Dorfman disease: a case report. J Neuro-Oncol 2000; 47: 73–77.

20. Adeleye AO, Amir G, Fraifeld S et al. Diagnosis and management of Rosai-Dorfmandisease involving the central nervous system. Neurol Res 2010; 32(6): 572–578. doi: 10.1179/016164109X12608733393836.

21. Kumar YA, Peng PY, Chen XC. Intracranial Rosai-Dorfman disease. Cas Rep Radiol 2014; 724379. doi: 10.1155/2014/724379.

22. Govender D, Chetty R. Inflammatory pseudotumour and Rosai-Dorfman disease of soft tissue: a histological continuum?. J Clin Pathol 1997; 50(1): 79–81. doi: 10.1136/jcp.50.7.620-b

23. Zumaeta J, Palacios F, Anicama W et al. Isolated intracranial Rosai-Dorfman disease: case report. Peru J Neurosurg 2020; 2(1): 15–21.

24. Deodhare SS, Ang LC, Bilbao JM. Isolated intracranial involvement in Rosai-Dorfman disease: a report of two cases and review of the literature. Arch Pathol Lab Med 1998; 122(2): 161–165.

25. Sandoval-Sus JD, Sandoval-Leon AC, Chapman JR et al. Rosai-Dorfman disease of the central nervous system: report of 6 cases and review of the literature. Medicine (Baltimore) 2014; 93(3): 165–175. doi: 10.1097/MD.0000000000000030.

26. Sasidharan A, Verma A, Epari S et al. Symptomatic Intracranial Rosai-Dorfman Disease in the Suprasellar Region Treated with Conformal Radiotherapy – A Report of Two Cases and Literature Review. Neurol India 2020; 68: 489–492. doi: 10.4103/0028-3886.284371.